Berkshire Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.21M Buy
35,024
+340
+1% +$39.3K 0.18% 70
2025
Q4
$3.65M Sell
34,684
-2,663
-7% -$250K 0.16% 77
2025
Q3
$3.13M Buy
37,347
+206
+0.6% +$17K 0.13% 91
2025
Q2
$2.94M Sell
37,141
-981
-3% -$78K 0.13% 90
2025
Q1
$2.96M Sell
38,122
-301,906
-89% -$28.2M 0.14% 86
2024
Q4
$32.5M Sell
340,028
-6,398
-2% -$660K 1.54% 31
2024
Q3
$42.9M Hold
346,426
2.18% 11
2024
Q2
$42.9M Buy
346,426
+16,955
+5% +$2.18M 2.14% 11
2024
Q1
$43.5M Sell
329,471
-1,655
-0.5% -$204K 2.3% 10
2023
Q4
$36.1M Sell
331,126
-1,643
-0.5% -$171K 2.06% 14
2023
Q3
$34.3M Sell
332,769
-2,165
-0.6% -$233K 2.14% 14
2023
Q2
$38.6M Buy
334,934
+3,902
+1% +$443K 2.29% 14
2023
Q1
$35.2M Sell
331,032
-4,779
-1% -$516K 2.18% 16
2022
Q4
$37.3M Buy
335,811
+2,186
+0.7% +$223K 2.39% 13
2022
Q3
$28.7M Sell
333,625
-1,122
-0.3% -$100K 2.03% 19
2022
Q2
$30.5M Buy
334,747
+12,162
+4% +$1.08M 1.99% 19
2022
Q1
$26.5M Buy
322,585
+7,975
+3% +$629K 1.67% 28
2021
Q4
$24.1M Buy
314,610
+4,111
+1% +$327K 1.47% 29
2021
Q3
$23.3M Buy
310,499
+7,635
+3% +$581K 1.56% 27
2021
Q2
$23.6M Buy
302,864
+9,409
+3% +$700K 1.59% 27
2021
Q1
$21.6M Buy
293,455
+2,676
+0.9% +$197K 1.6% 27
2020
Q4
$22.7M Buy
290,779
+25,136
+9% +$1.92M 1.75% 25
2020
Q3
$21M Sell
265,643
-27,538
-9% -$2.16M 2.03% 24
2020
Q2
$21.6M Buy
293,181
+14,091
+5% +$1.06M 1.99% 19
2020
Q1
$20.5M Buy
279,090
+6,104
+2% +$480K 2.13% 15
2019
Q4
$23.7M Sell
272,986
-9,274
-3% -$762K 2.01% 18
2019
Q3
$22.7M Buy
282,260
+7,860
+3% +$630K 1.95% 22
2019
Q2
$22M Buy
274,400
+3,061
+1% +$234K 1.82% 22
2019
Q1
$21.5M Sell
271,339
-613
-0.2% -$45.8K 1.83% 23
2018
Q4
$19.8M Buy
271,952
+2,049
+0.8% +$145K 1.85% 20
2018
Q3
$18.3M Buy
269,903
+13,420
+5% +$855K 1.55% 27
2018
Q2
$14.9M Buy
256,483
+10,533
+4% +$594K 1.39% 30
2018
Q1
$12.8M Buy
245,950
+15,941
+7% +$861K 1.24% 32
2017
Q4
$12.3M Buy
230,009
+33,088
+17% +$1.83M 1.2% 34
2017
Q3
$12M Sell
196,921
-272
-0.1% -$16.5K 1.34% 31
2017
Q2
$12.1M Buy
197,193
+4,101
+2% +$250K 1.37% 29
2017
Q1
$11.7M Buy
193,092
+7,569
+4% +$459K 1.39% 27
2016
Q4
$10.4M Buy
185,523
+15,084
+9% +$883K 1.35% 29
2016
Q3
$10.2M Buy
170,439
+9,193
+6% +$538K 1.46% 27
2016
Q2
$8.86M Sell
161,246
-10,219
-6% -$544K 1.35% 29
2016
Q1
$8.66M Buy
171,465
+15,975
+10% +$782K 1.35% 31
2015
Q4
$7.84M Buy
155,490
+5,290
+4% +$267K 1.3% 30
2015
Q3
$7.08M Buy
150,200
+7,755
+5% +$412K 1.26% 31
2015
Q2
$7.74M Buy
142,445
+3,687
+3% +$207K 1.3% 27
2015
Q1
$7.61M Buy
138,758
+2,054
+2% +$116K 1.27% 29
2014
Q4
$7.41M Buy
136,704
+3,363
+3% +$187K 1.27% 28
2014
Q3
$7.54M Buy
133,341
+1,486
+1% +$83.4K 1.39% 26
2014
Q2
$7.28M Sell
131,855
-8,835
-6% -$482K 1.35% 29
2014
Q1
$7.62M Sell
140,690
-1,650
-1% -$85.4K 1.47% 24
2013
Q4
$6.8M Buy
142,340
+17,428
+14% +$797K 1.28% 29
2013
Q3
$5.67M Buy
124,912
+20,896
+20% +$954K 1.37% 27
2013
Q2
$4.61M Buy
+104,016
New +$4.65M 1.28% 27

Other funds holding MRK

Berkshire Asset Management's MRK Position: Q1 2026 in Review

Berkshire Asset Management increased its Merck (MRK) stake by 0.98% in Q1 2026, buying an estimated $39.3K and bringing the position to 35,024 shares worth $4.21M. The position accounts for 0.18% of the portfolio, ranked #70.

Berkshire Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $43.5M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Berkshire Asset Management held 35,024 shares of Merck worth $4.21M as of Q1 2026.
  • Berkshire Asset Management bought 340 Merck shares in Q1 2026, an estimated $39.3K.
  • Merck made up 0.18% of Berkshire Asset Management's portfolio in Q1 2026, its #70 holding.
  • Berkshire Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Berkshire Asset Management's Merck position peaked at $43.5M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Berkshire Asset Management's 13F filing for Q1 2026, filed 11 May 2026.